Aikido Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AIKI Nasdaq 8731 https://aikidopharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aikido Pharma Inc

AIkido Inc. Announces the Formation of a New Financial Services Subsidiary - Jun 24th, 2022 1:00 pm
Significant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to Stockholders - Jun 21st, 2022 8:30 pm
AIkido Pharma Inc. Appoints New Director, Soo Yu - Jun 10th, 2022 8:15 pm
Significant Investor in AIkido Pharma Issues Open Letter to Board of Directors - Jun 7th, 2022 8:30 pm
AIkido Announces Reverse Stock Split - Jun 3rd, 2022 8:30 pm
AIkido Pharma Announces Company Commitment to Board Diversity - May 19th, 2022 12:30 pm
AIkido Pharma Secures Interest in Databricks Inc. - May 12th, 2022 7:40 pm
AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans - May 11th, 2022 11:10 am
AIkido Reports Slinger Bag Inc.'s Filing for Nasdaq Public Listing - May 5th, 2022 1:45 pm
AIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc. - May 4th, 2022 7:29 pm
Glass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharma Inc. Proposed Reverse Stock Split - Apr 22nd, 2022 2:00 pm
AIkido Pharma Announces Strategic Investment in MasterClass - Apr 5th, 2022 6:00 pm
Cedars-Sinai Medical Center and AIkido Pharma Inc. to Codevelop Novel Immuno-Oncology Cancer Treatment - Mar 11th, 2022 3:00 pm
Cedars-Sinai Medical Center and AIkido Pharma Inc. Enter Into Master Collaboration Agreement - Mar 8th, 2022 6:30 pm
AIkido Pharma Reports Improved Manufacturing Process and New United States Patent for Pancreatic Drug - Mar 3rd, 2022 3:00 pm
AIkido Pharma Inc. Announces Closing of $22 Million Registered Direct Offering - Mar 2nd, 2022 10:09 pm
AIkido Pharma Inc. Announces $22 Million Registered Direct Offering - Feb 25th, 2022 1:00 pm
AIkido Pharma Announces Share Repurchase Program - Jan 24th, 2022 6:30 pm
AIkido Pharma Announces Dr. Rachel Yehuda's Appearance on CBS News - Jan 5th, 2022 3:00 pm
AIkido Pharma Reports Filing for Expanded Worldwide Patent Coverage on Key Assets - Dec 14th, 2021 3:00 pm